藥用輔料市場規模、佔有率、成長分析（按產品類型、功能、配方、來源、最終用戶、地區）- 2025-2032 年產業預測

2023 年全球藥用輔料市場規模為 91 億美元，預計將從 2024 年的 96.3 億美元成長到 2032 年的 151.2 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

由於對創新藥物的需求不斷增加以及藥物輸送技術的進步，藥用輔料市場預計將大幅成長。開發新藥投資的增加和學名藥需求的激增為輔料製造商創造了充足的機會。此外，全球製藥製造活動的擴張預計將進一步提升市場前景。生物製藥銷售的擴大可能會增加對特殊輔料的需求。然而，生產成本上升、法規嚴格、原料供應波動以及替代品的競爭等挑戰可能會阻礙市場進步。預計北美和亞太地區仍將是藥用輔料的主要市場，這表明未來幾年這些地區將具有巨大的商業性潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

藥用輔料市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概覽
• 有機化學品
  • 碳水化合物
  • 糖
  • 澱粉
  • 纖維素及其衍生物
  • 石化產品
  • 乙二醇
  • 聚維酮
  • 礦物碳氫化合物
  • 蛋白質
  • 明膠
  • 白蛋白
• 無機化學品
  • 磷酸鈣
  • 碳酸鈣
  • 硬脂酸鎂
  • 氯化鈉
  • 二氧化矽
• 其他
  • 油脂化工產品
  • 天然輔料

藥用輔料市場規模：功能與複合年成長率（2025-2032）

• 市場概覽
• 黏合劑
• 填充劑/稀釋劑
• 崩壞
• 被覆劑
• 潤滑劑
• 防腐劑
• 香料和甜味劑
• 著色劑
• 溶劑
• 其他

藥用輔料市場規模（按配方和複合年成長率） (2025-2032)

• 市場概覽
• 口服製劑
  • 藥片
  • 膠囊
  • 粉末
  • 糖漿
• 局部製劑
  • 奶油
  • 軟膏
  • 凝膠
• 腸外製劑
  • 注射
  • 點滴
• 吸入劑型
  • 乾粉吸入器（DPI）
  • 定量噴霧吸入器（MDI）
• 眼藥水
• 鼻腔製劑
• 栓劑

藥用輔料市場規模（按來源和複合年成長率）（2025-2032）

• 市場概覽
• 自然的
  • 植物來源
  • 動物來源
• 合成
  • 全合成
  • 半合成

藥用輔料市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 製藥公司
• 生物製藥公司
• 契約製造組織（CMO）
• 合約研究組織（CRO）

藥用輔料市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Evonik Industries AG-Germany
• Ashland Global Holdings Inc.-USA
• International Flavors & Fragrances Inc.-USA
• Roquette Freres-France
• Fuji Chemical Industries Co., Ltd.-Japan
• Wacker Chemie AG-Germany
• MEGGLE GmbH & Co. KG-Germany
• Key Developments
• Biogrund GmbH-Germany
• Nitika Pharmaceutical Specialties Pvt. Ltd.-India
• JM Huber Corporation-USA
• Kerry Group plc-Ireland
• Colorcon Inc.-USA
• Merck KGaA-Germany
• DFE Pharma-Germany
• Finar Limited-India
• Corel Pharma Chem-India
• Gattefosse-France
• BASF SE-Germany
• DowDuPont Inc.-USA

結論和建議

Global Pharmaceutical Excipients Market size was valued at USD 9.1 billion in 2023 and is poised to grow from USD 9.63 billion in 2024 to USD 15.12 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The pharmaceutical excipients market is poised for significant growth driven by rising demand for innovative drugs and advancements in drug delivery technologies. Increased investments in novel drug development and a surging demand for generic medications present ample opportunities for excipient manufacturers. Additionally, the global expansion of pharmaceutical manufacturing activities is expected to further enhance market prospects. The growing sales of biologics will likely boost demand for specialized excipients. However, challenges such as high manufacturing costs, stringent regulations, raw material supply fluctuations, and competition from alternatives may hinder market progress. North America and the Asia Pacific regions are projected to remain the dominant markets for pharmaceutical excipients, indicating robust commercial potential in these areas in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global Pharmaceutical Excipients Market is segmented by Product Type, Functionality, Formulation, Source, End User and region. Based on Product Type, the market is segmented into Organic Chemicals, Inorganic Chemicals and Others. Based on Functionality, the market is segmented into Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants, Preservatives, Flavors and Sweeteners, Coloring Agents, Solvents and Others. Based on Formulation, the market is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations, Inhalation Formulations, Ophthalmic Formulations, Nasal Formulations and Suppositories. Based on Source, the market is segmented into Natural and Synthetic. Based on End User, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Excipients Market

The escalating costs of drugs and pharmaceuticals globally have sparked a significant surge in the demand for generic medicines. This trend is fueled by a rising focus on enhancing healthcare accessibility and lowering overall healthcare expenses. As a result, the market for generic medicines is expected to see substantial growth, which, in turn, will positively influence the development of the pharmaceutical excipients market. The increasing popularity of generic alternatives is driving innovation and competition, further propelling advancements within the excipients sector, making it an essential component of the pharmaceutical manufacturing process as the industry adapts to these market dynamics.

Restraints in the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market faces significant restraints primarily due to the high research and development costs associated with excipient formulation. The intricate development process necessitates extensive investment throughout the entire product lifecycle, which can elevate overall expenses. Additionally, the growing reliance on advanced manufacturing equipment further contributes to these elevated production costs. As a result, this combination of high development and manufacturing expenses is likely to hinder sales growth in the pharmaceutical excipients sector in the foreseeable future, posing challenges for market expansion and profitability.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a significant trend towards the incorporation of natural and biodegradable ingredients. As consumers increasingly gravitate towards wellness and sustainability, there is a rising demand for drug formulations that utilize natural excipients, steering away from traditional chemical-based alternatives. This shift is driven by a growing demographic that prioritizes health-conscious choices and seeks transparency in product formulations. Consequently, pharmaceutical excipient manufacturers are presented with lucrative opportunities to innovate and expand their product lines by integrating eco-friendly components, thereby aligning with consumer preferences and contributing to the overall growth of this dynamic market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Organic Chemicals
  • Carbohydrates
  • Sugars
  • Starches
  • Cellulose and Derivatives
  • Petrochemicals
  • Glycols
  • Povidone
  • Mineral Hydrocarbons
  • Proteins
  • Gelatin
  • Albumin
• Inorganic Chemicals
  • Calcium Phosphates
  • Calcium Carbonate
  • Magnesium Stearate
  • Sodium Chloride
  • Silicon Dioxide
• Others
  • Oleochemicals
  • Natural Excipients

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2025-2032)

• Market Overview
• Binders
• Fillers/Diluents
• Disintegrants
• Coating Agents
• Lubricants
• Preservatives
• Flavors and Sweeteners
• Coloring Agents
• Solvents
• Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Oral Formulations
  • Tablets
  • Capsules
  • Powders
  • Syrups
• Topical Formulations
  • Creams
  • Ointments
  • Gels
• Parenteral Formulations
  • Injections
  • IV Infusions
• Inhalation Formulations
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
• Ophthalmic Formulations
• Nasal Formulations
• Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2025-2032)

• Market Overview
• Natural
  • Plant-based
  • Animal-based
• Synthetic
  • Fully synthetic
  • Semi-synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2025-2032)

• North America (Product Type, Functionality, Formulation, Source, End User)
  • US
  • Canada
• Europe (Product Type, Functionality, Formulation, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Functionality, Formulation, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Evonik Industries AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Flavors & Fragrances Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGGLE GmbH & Co. KG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Biogrund GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nitika Pharmaceutical Specialties Pvt. Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.M. Huber Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Finar Limited - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corel Pharma Chem - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DowDuPont Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations